학술논문

Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study
Document Type
Journal
Source
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY; NOV 29 2021, 9p.
Subject
Language
English
ISSN
1468330X